Ivan Rich

Ivan Rich is the President of Preferred Cell Systems, a company specializing in assay kit products for stem cell and veterinary research, cellular therapy, and life sciences. He has held this position since 2017.4

Professional Background

Rich has an extensive background in the biotech industry. He is also the Founder, Chairman, and CEO of HemoGenix, Inc., a position he has held since 2000.4 HemoGenix and Preferred Cell Systems are sister companies, with HemoGenix focusing on contract research services while Preferred Cell Systems manufactures and supplies reagents and in vitro assays.2

Academic Involvement

In addition to his corporate roles, Ivan Rich has maintained an academic presence. He has been a Professor and Director of Basic Research since 1996, though the specific institution is not mentioned in the provided search results.4

Expertise and Recognition

Rich is highly regarded in his field:

• He holds a PhD and is cited by 2,030 other researchers.5
• He has authored 149 publications, indicating significant contributions to scientific literature.5

Company Overview

Preferred Cell Systems, under Rich's leadership, is:

• A global resource for innovative, high-quality assay kits and cell culture media for the life sciences.1
• The exclusive manufacturer and supplier of all reagents and in vitro assays originally produced by HemoGenix.1

The company is based in Colorado Springs, Colorado.3